A new study from Finnish scientists at the University of Helsinki reveals that the cardiovascular benefits of eicosapentaenoic acid (EPA)—a key Omega-3 fatty acid found in fish oil—may vanish rapidly after supplementation ends.
More critically, the study shows that EPA’s effects vary significantly between individuals, depending on their unique metabolic profiles. This finding challenges the prevailing assumption that omega-3 supplements offer uniform protection against heart disease and underscores the need for personalised health strategies.
Key Findings
Short-lived EPA spikes: Participants experienced substantial but temporary increases in EPA levels, which declined quickly after stopping supplementation.
Metabolic variability: Individual lipid profiles responded differently to EPA, suggesting that metabolism plays a decisive role in how omega-3s are processed and utilised.
Implications for healthy adults: While EPA is known to benefit those with high cholesterol or cardiovascular disease, its impact on otherwise healthy individuals remains inconsistent and poorly understood.
Strategic Implications
Policy & Regulation: This research may prompt regulatory bodies, such as NAFDAC, to revisit blanket endorsements of omega-3 supplements and consider guidelines that reflect metabolic diversity.
Consumer Trust: The findings could disrupt the nutraceutical market, where omega-3 products are often marketed as universally beneficial. Brands may need to pivot toward personalised formulations or diagnostics.
Public Health Messaging: Health campaigns may need to shift from generic supplement advice to more targeted interventions based on individual risk profiles and metabolic data.
Market Context
The global omega-3 supplement market is valued at over $5 billion annually, with intense penetration in urban Nigerian markets.
Cardiovascular disease remains one of Nigeria’s leading causes of mortality, making heart health interventions a high-stakes domain for both public and private actors.
Intelligence Outlook
This study marks a turning point in understanding and applying the efficacy of omega-3. For Nigeria, where supplement use is rising and cardiovascular risk is high, the findings offer both a cautionary tale and an opportunity: to lead in personalised nutrition policy and reshape consumer expectations around preventive health.